Angola - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Angola Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases was up 37.8% year on year. In 2019, the country was ranked number 31 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 1,523 Cases. Angola is overtaken by North Korea, which was ranked number 30 with 1,528 Cases and is followed by Peru with 1,409 Cases. India lead the ranking with 66,255 Cases in 2019, a growth of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 1,523.00 |
| 2018 | 649.00 |
| 2017 | 534.00 |
| 2016 | 167.00 |
| 2015 | 227.00 |
How does Angola rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 29 |
#29
Peru
|
1,894 | 2019 | -2.5 % | +5.3 % | View data | |
| 31 |
#31
Angola
|
1,523 | 2019 | +134.7 % | +37.8 % | View data | |
| 33 |
#33
Kyrgyzstan
|
1,403 | 2019 | +2.4 % | +2.1 % | View data | |